Aim of the studyThe crisis associated with cancer may contribute to the development of anxiety and depressive disorders. Contemporary psycho-oncology focuses on the psychological determinants of the cancer patients functioning to find which disease-coping strategies help the healing process, facilitate the establishment of a good therapeutic relationship and the process of adapting to difficult situations. Aim of the study was assess the psychological functioning of patients with cancer of reproductive organs in the cancer-treating process. The practical aim was to develop guidelines for psychological care dedicated to this group of patients.Material and methodsThe study was conducted in the Reproductive Organs Cancer Clinic in Institute of Oncology in Warsaw using a questionnaire consisting of: Demographic, Hospital Anxiety and Depression Scale (HADS), Multidimentional Health Locus of Control (MHLC), Cognitive Emotions Regulations Questionaire (CERQ).ResultsSeventy-eight patients aged 22 to 82 (average 54) were examined. Investigation of relationships between anxiety and depression and coping strategies showed: positive correlation of anxiety with self blame and rumination, positive correlation of anxiety and depression with catastrophizing, positive correlation of depression with blaming others, negative correlation of anxiety and depression with acceptance and positive refocusing, negative correlation of depression with refocus of planning and putting into perspective.ConclusionsThe results of this study indicate that there may be an indirect method of diagnosing anxiety and depression disorders in cancer patients by observing the coping strategies to cope with the difficult situation.
This double-blind, randomised, parallel-group trial compared the analgesic efficacy of single 50 mg doses of diclofenac potassium sachets and tablets with placebo in 184 patients with moderate/severe pain after third molar extraction. The primary efficacy variable was the average pain reduction from baseline during the first 2-h postdose, using a visual analogue scale (VAS). During the first 2-h postdose, sachets and tablets significantly reduced pain (p < 0.05) vs. placebo with an incremental benefit seen for sachets over tablets (p < 0.05). Onset of analgesic effect (VAS) was at 30 min for sachets and 45 min for tablets. Pain reduction vs. placebo (VAS) was maintained for 8 h for sachets and tablets (p < 0.05). VAS-findings were confirmed by pain relief and intensity verbal scale assessments. Fewer patients re-medicated vs. placebo. No safety issues were identified. This study demonstrates that both diclofenac potassium sachets and tablets offer patients suffering from acute pain conditions an effective treatment with incremental analgesic benefits seen for sachets.
IntroductionContemporary psycho-oncology focuses on the study of the psychological determinants of the functioning of cancer patients. Among the psychological factors that significantly affect the functioning of the patients are anxiety and depressive disorders.AimTo assess the psychological functioning of patients with digestive system cancer in the cancer-treating process and to develop guidelines for psychological care dedicated to this group of patients based on the results of the study.Material and methodsA total of 69 patients aged 23 to 91 (average 56) years with digestive system cancer treated in the Gastroenterology Cancer Clinic in the Institute of Oncology in Warsaw were examined using HADS, Mini-MAC, and MHLC. The results were analysed using statistical tests and correlation analysis. Another 532 patients from other wards formed the reference group.ResultsMeasured HLC, anxiety, and depression did not differ significantly from the overall patient population. The investigation of the relationships between anxiety and depression and mental adjustment to cancer showed a positive correlation between anxiety and depression and anxious preoccupation and hopelessness-helplessness, and negative correlation between anxiety and depression and fighting spirit.ConclusionsThe obtained research results on the correlation of anxiety and depression with health locus of control show that the lower the severity of anxiety and depression, the higher the severity of internal health locus of control. The results confirm the necessity of psychological support forcancer patients showing evidence of destructive attitudes and external health locus of control, so that the severity of anxiety-depressive disorders can indirectly be reduced.
S t r e s z c z e n i eCel pracy: Wielowymiarowa ocena bólu u pacjentów z nowotworem piersi oraz nowotworami żeńskich i męskich narządów płciowych. Materiał i metody:Badaniem objęto 300 pacjentów onkologicznych w trakcie leczenia przyczynowego w wieku 25-96 lat (średnia wieku 65,4 lata) zgłaszających się do poradni leczenia bólu. Badanie przeprowadzono w celu jakościowego badania charakterystyk bólu przy użyciu narzędzi standaryzowanych według 11-stopniowej skali NRS służącej do oceny natężenia bólu oraz Arkusza Doznań Bólowych.Wyniki: Dziewięćdziesiąt procent badanych zgłosiło ból o średnim (4-6 pkt NRS) lub wysokim (7-10 pkt NRS) natężeniu. Ocena bólu w wymiarze afektywnym i oceniającym wskazała, że najbardziej dokuczliwy dla pacjentów okazywał się ból stały o zmiennym nasileniu lub stały o jednakowym nasileniu. Pacjenci opisywali ból stały o zmiennym nasileniu w kategoriach: potwornego, okrutnego, strasznego, nieznośnego, nie do wytrzymania, wyczerpującego. We wszystkich badanych rodzajach nowotworów najczęściej zgłaszanym bólem był ból ostry.Wnioski: Ból ma wielowymiarowy charakter, dlatego w jego ocenie niewystarczające jest określenie jedynie nasilenia, ale także konieczne jest poznanie jego etiologii, lokalizacji, częstości występowania oraz jego wymiaru afektywnego, sensorycznego i behawioralnego.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.